Effects of Single, Short-term Exposures of Human Retinal Pigment Epithelial Cells to Thiotepa or 5-fluorouracil: Implications for the Treatment of Proliferative Vitreoretinopathy
Overview
Affiliations
Aim: To investigate the effects of single, short-term (5 or 30 minutes) exposures to thiotepa or 5-fluorouracil (5-FU) on collagen lattice contraction and retinal pigment epithelial (RPE) cell proliferation.
Methods: For collagen contraction studies, RPE cells seeded into free floating type I collagen lattices were exposed to single 5 or 30 minute treatments with thiotepa (0.06-4 mg/ml), or 5-FU (0.25-25 mg/ml), or phosphate buffered saline alone as a control. For proliferation studies, RPE cell monolayers were similarly exposed to these agents. The degree of contraction, effects on cell number, and viability were determined up to 14 days after treatment.
Results: Contraction of collagen lattices containing RPE cells and proliferation of RPE cells were significantly inhibited (p < 0.05) by thiotepa and 5-FU at concentrations above 0.06 mg/ml and 0.25 mg/ml respectively (for both 5 and 30 minute treatments), compared with controls. Cell death did not occur except for exposure of the RPE cells in collagen lattices to the highest concentration of thiotepa (4 mg/ml).
Conclusion: It was concluded that single 5 or 30 minute exposures to thiotepa or 5-FU significantly inhibited collagen contraction and the proliferation of RPE cells. These findings suggest that short, single, non-toxic exposures to thiotepa or 5-FU which can be reproduced clinically may be useful in the modulation of proliferative vitreoretinopathy.
Chen C, Chen P, Liu X, Li H Front Med (Lausanne). 2021; 8:790460.
PMID: 34917641 PMC: 8669826. DOI: 10.3389/fmed.2021.790460.
In Vitro Cell Models for Ophthalmic Drug Development Applications.
Shafaie S, Hutter V, Cook M, Brown M, Chau D Biores Open Access. 2016; 5(1):94-108.
PMID: 27158563 PMC: 4845647. DOI: 10.1089/biores.2016.0008.
Priglinger C, Obermann J, Szober C, Merl-Pham J, Ohmayer U, Behler J PLoS One. 2016; 11(1):e0146887.
PMID: 26760037 PMC: 4712018. DOI: 10.1371/journal.pone.0146887.
Quinotrierixin inhibits proliferation of human retinal pigment epithelial cells.
Chen C, Wang J, Li J, Yu Q, Zhang S Mol Vis. 2013; 19:39-46.
PMID: 23335849 PMC: 3541046.
The clinical applications of fluorouracil in ophthalmic practice.
Abraham L, Selva D, Casson R, Leibovitch I Drugs. 2007; 67(2):237-55.
PMID: 17284086 DOI: 10.2165/00003495-200767020-00005.